Respiratory Pathogen Panel (RPP)

Respiratory infections are caused by both bacteria and viruses located in the upper respiratory tract of patients. Innovative Gx Laboratories’ Respiratory Pathogen Panel (RPP) is a molecular diagnostic test that will rapidly identify a wide range of respiratory pathogens using both Polymerase Chain Reaction (PCR) and Reverse Transcription Polymerase Chain Reaction (RT PCR). Both PCR and RT-PCR technologies precisely identify the correct pathogen(s) present in the infection and will also detect antibiotic drug resistance contained in the pathogen. This precision diagnostic test delivers quick and highly accurate results to the physician (routinely same day results upon receipt by our laboratory) and allows providers the ability to prescribe timely and effective treatment, rather than a trial-and-error approach.

Acute respiratory infection is a significant cause of morbidity and mortality in young, geriatric and immunocompromised patients. Co-infection is also high within these populations and access to advanced technology is essential to detect multiple pathogens at once. False negative test results can lead to a delayed diagnosis and poor clinical outcomes.

The Innovative Gx Laboratories’ Respiratory Pathogen Test (RPP) quickly identifies pathogens and detects potential antibiotic resistance so that effective treatment can begin sooner.

Accurate diagnosis within 24 hours with real-time PCR and RT PCR for pathogen identification and detection of antibiotic resistance

  • Provides a more definitive diagnosis than point of care antigen assays
  • 24-hour turnaround from specimen receipt
  • More accurate, without the wait times of conventional culture
  • CLIA accredited laboratory

Helps improve clinical confidence and decrease patient risks

  • Detects polymicrobial infections
  • Unaffected by concurrent antibiotic use
  • Identifies potential antibiotic resistance
  • Aids in quick clinical decision-making
  • Reduces false negative results
  • Aids in antibiotic stewardship
  • Reduces potential unnecessary drug exposure and adverse events

Respiratory Pathogen Panel Menu

Viral

  • Coronavirus Combo
  • Cytomegalovirus (HHV5)
  • EBV
  • Enterovirus D68
  • Human Bocavirus
  • Human Herpesvirus 6 (HHPV)
  • Human Metapneumovirus (hMPV)
  • Human Parechovirus
  • Human Rhinovirus 1
  • Human Rhinovirus 2
  • Influenza A
  • Influenza A H1
  • Influenza A H3
  • Influenza B
  • Measles virus
  • Mumps virus
  • Parainfluenza 1-2-3
  • Parainfluenza 4
  • Respiratory syncytial virus (RSV)
  • Varicella Zoster virus (HHV3)

Bacterial/Fungal

  • Candida species
  • Haemophilus influenzae
  • Bordetella pertussis
  • Chlamydophila pneumoniae
  • Klebsiella species
  • Mycobacterium tuberculosis
  • Mycoplasma pneumoniae
  • Pseudomonas aeruginosa
  • Staphylococcus aureus
  • Streptococcus pneumoniae
  • Streptococcus pyogenes (Group A Strep)

Antibiotic Resistance Panel Menu

  • Class C Beta-lactams resistance
  • Class A Beta-lactams resistance (B-Lac_CTX-M1_M2_M9_M8-25)
  • Class A Beta-lactams resistance (B-Lac_SHV_KPC)
  • Extended Spectrum Beta-lactams resistance
  • Trimethoprim/Sulfamethoxazole resistance
  • Macrolides resistance
  • Class B Beta-lactams resistance
  • Methicillin resistance
  • Class D Beta-lactams resistance
  • Fluoroquinolone resistance
  • Tetracycline resistance
  • Vancomycin resistance

Need Help?

Visit the Innovative IGx Help Center

Get Help